Publication | Closed Access

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyPathologyRichter TransformationAdult T-cell Leukemia-lymphomaObinutuzumab CombinationOncologyRadiation OncologyLarge B-cell LymphomaHealth Sciences